Glück Conviction Score™ ⓘ
ZBIO
Zenas BioPharma, Inc.
Effektiv: Stark
Niedrig
Bedeutung der Einstufung ⓘ
Insider
86,3
3 Insider, 7,6M $ Volumen
Institutionell
64,8
64 neu, 57 erhöht, -242769K $ netto
Aktivist
70,3
13D-Filing vorhanden
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 19.45 | +1.8 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 24.64 | -19.7 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 53 Tagen @ 18.21 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 18.47 | EMA50: 19.54 | |
| MACD-Histogramm | Bullisch | 10 % | 0.177 | Bullisch | |
| RSI(14) | Neutral | 10 % | 55.8 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 91.0 | Überkauft | |
| ADX(14)+DI | Neutral | 10 % | 14.6 | +DI: 26.0 / −DI: 18.6 | |
| Z-Score(60) | Neutral | 5 % | 0.08 | In Range | |
| 52W-Position | Neutral | 5 % | 31.3 % | Hoch 43.17 / Tief 9.14 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 97.8 % | Upper 19.87 / Mid 18.26 / Lower 16.66 | |
| LinReg-Slope(60) | Bärisch | 10 % | -0.0648 | R²=0.49 / annualisiert -83.0 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 60.000 | 16,88 | 1.012.800,00 | +87,2% | |
| 2026-04-29 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 35.000 | 17,62 | 616.700,00 | +53,1% | |
| 2026-04-28 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 25.000 | 18,02 | 450.500,00 | +38,8% | |
| 2026-03-31 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 34.000 | 19,31 | 656.540,00 | +56,5% | |
| 2026-03-31 | Lu Hongbo | Director | Open Market Purchase | 75.000 | 20,00 | 1.500.000,00 | +129,1% | |
| 2026-03-31 | Lu Hongbo | Director | Open Market Purchase | 3.768 | 18,63 | 70.197,84 | +6,0% | |
| 2026-03-31 | Fairmount Funds Management LLC | Director | Open Market Purchase | 150.000 | 20,00 | 3.000.000,00 | +258,2% | |
| 2026-03-30 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 20.000 | 18,23 | 364.600,00 | +31,4% | |
| 2026-02-13 | Allen Patricia L | Director | Open Market Purchase | 4.160 | 26,36 | 109.657,60 | +9,4% | |
| 2026-02-12 | Allen Patricia L | Director | Open Market Purchase | 5.000 | 26,50 | 132.500,00 | +11,4% | |
| 2026-02-12 | Allen Patricia L | Director | Open Market Purchase | 5.700 | 24,34 | 138.738,00 | +11,9% | |
| 2026-02-12 | Allen Patricia L | Director | Open Market Purchase | 5.000 | 23,77 | 118.850,00 | +10,2% | |
| 2026-02-11 | Lu Hongbo | Director | Open Market Purchase | 25.985 | 22,50 | 584.662,50 | +50,3% | |
| 2026-02-02 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 57.000 | 17,96 | 1.023.720,00 | +88,1% | |
| 2026-01-09 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 20.000 | 16,55 | 331.000,00 | +28,5% | |
| 2026-01-08 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 30.000 | 16,30 | 489.000,00 | +42,1% | |
| 2026-01-07 | MOULDER LEON O JR | Director, Officer, Chief Executive Officer | Open Market Purchase | 50.000 | 16,38 | 819.000,00 | +70,5% | |
| 2025-10-09 | ENRIGHT PATRICK G | Director | Open Market Purchase | 11.990 | 20,85 | 249.991,50 | +21,5% | |
| 2025-10-09 | ENRIGHT PATRICK G | Director | Open Market Purchase | 105.265 | 19,00 | 2.000.035,00 | +172,1% | |
| 2025-10-09 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | Open Market Purchase | 63.158 | 19,00 | 1.200.002,00 | +103,3% | |
| 2025-10-09 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | Open Market Purchase | 63.157 | 19,00 | 1.199.983,00 | +103,3% | |
| 2025-10-09 | Nunn Jason Raleigh | Director | Open Market Purchase | 63.158 | 19,00 | 1.200.002,00 | +103,3% | |
| 2025-10-07 | Lu Hongbo | Director | Open Market Purchase | 263.160 | 19,00 | 5.000.040,00 | +430,3% | |
| 2025-10-07 | Fairmount Funds Management LLC | Director | Open Market Purchase | 316.219 | 19,00 | 6.008.161,00 | +517,1% | |
| 2025-10-07 | MOULDER LEON O JR | Director, Officer, See Remarks | Open Market Purchase | 36.928 | 20,85 | 769.948,80 | +66,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| FMR LLC | 9.082.000 | 7.704.255 | 1.377.745 | 177.553.101 | Aufgestockt | +17,9% | |
| SR ONE CAPITAL MANAGEMENT, LP | 5.037.854 | 5.037.854 | 0 | 98.490.046 | Unverändert | 0,0% | |
| NEA Management Company, LLC | 4.023.219 | 3.523.219 | 500.000 | 78.653.931 | Aufgestockt | +14,2% | |
| Enavate Sciences GP, LLC | 3.919.159 | 3.919.159 | 0 | 76.619.558 | Unverändert | 0,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 65.000.000 | 0 | 65.000.000 | 67.252.900 | Neu | +100,0% | |
| FEDERATED HERMES, INC. | 3.127.031 | 2.715.578 | 411.453 | 61.133.456 | Aufgestockt | +15,2% | |
| VANGUARD GROUP INC | 1.453.065 | 0 | 1.453.065 | 52.760.791 | Neu | +100,0% | |
| Novo Holdings A/S | 1.450.000 | 0 | 1.450.000 | 52.649.500 | Neu | +100,0% | |
| Polar Capital Holdings Plc | 2.548.444 | 1.057.609 | 1.490.835 | 49.822.080 | Aufgestockt | +141,0% | |
| Capital International Investors | 2.434.000 | 0 | 2.434.000 | 47.584.700 | Neu | +100,0% | |
| Fairmount Funds Management LLC | 2.359.025 | 2.209.025 | 150.000 | 46.118.939 | Aufgestockt | +6,8% | |
| BlackRock, Inc. | 2.037.548 | 1.767.518 | 270.030 | 39.834.063 | Aufgestockt | +15,3% | |
| NVP Associates, LLC | 1.838.482 | 1.838.482 | 0 | 35.942.323 | Unverändert | 0,0% | |
| ALLIANCEBERNSTEIN L.P. | 897.321 | 18.350 | 878.971 | 32.581.726 | Aufgestockt | +4790,0% | |
| Vivo Capital, LLC | 853.495 | 0 | 853.495 | 30.990.403 | Neu | +100,0% | |
| Context Capital Management, LLC | 29.100.000 | 0 | 29.100.000 | 30.118.500 | Neu | +100,0% | |
| STATE STREET CORP | 1.470.923 | 438.294 | 1.032.629 | 28.756.545 | Aufgestockt | +235,6% | |
| WELLINGTON MANAGEMENT GROUP LLP | 1.246.053 | 855.334 | 390.719 | 24.360.335 | Aufgestockt | +45,7% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.245.391 | 0 | 1.245.391 | 24.347.394 | Neu | +100,0% | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.135.935 | 0 | 1.135.935 | 22.207.529 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 20.000.000 | 21.726 | 19.978.274 | 19.792.600 | Aufgestockt | +91955,6% | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20.000.000 | 0 | 20.000.000 | 19.792.600 | Neu | +100,0% | |
| EcoR1 Capital, LLC | 789.500 | 789.500 | 0 | 15.434.725 | Unverändert | 0,0% | |
| Woodline Partners LP | 3.090.525 | 0 | 3.090.525 | 14.119.764 | Neu | +100,0% | |
| BRAIDWELL LP | 13.000.000 | 0 | 13.000.000 | 13.455.000 | Neu | +100,0% | |
| BALYASNY ASSET MANAGEMENT L.P. | 667.070 | 193.153 | 473.917 | 13.041.219 | Aufgestockt | +245,4% | |
| ArrowMark Colorado Holdings LLC | 658.909 | 751.161 | -92.252 | 12.881.671 | Reduziert | -12,3% | |
| GEODE CAPITAL MANAGEMENT, LLC | 655.785 | 588.393 | 67.392 | 12.823.976 | Aufgestockt | +11,5% | |
| Pivotal bioVenture Partners Investment Advisor LLC | 591.991 | 591.991 | 0 | 11.573.424 | Unverändert | 0,0% | |
| JANE STREET GROUP, LLC | 9.572.900 | 35.800 | 9.537.100 | 10.948.945 | Aufgestockt | +26639,9% | |
| CITADEL ADVISORS LLC | 8.127.670 | 56.759 | 8.070.911 | 10.790.866 | Aufgestockt | +14219,6% | |
| MILLENNIUM MANAGEMENT LLC | 1.676.818 | 49.160 | 1.627.658 | 10.553.536 | Aufgestockt | +3310,9% | |
| Point72 Asset Management, L.P. | 403.400 | 0 | 403.400 | 10.484.534 | Neu | +100,0% | |
| GREAT POINT PARTNERS LLC | 524.066 | 0 | 524.066 | 10.245.490 | Neu | +100,0% | |
| Jefferies Financial Group Inc. | 5.767.947 | 0 | 5.767.947 | 10.054.103 | Neu | +100,0% | |
| Rock Springs Capital Management LP | 502.077 | 502.077 | 0 | 9.815.605 | Unverändert | 0,0% | |
| MARSHALL WACE, LLP | 501.928 | 7.100 | 494.828 | 9.812.692 | Aufgestockt | +6969,4% | |
| NEXTBio Capital Management LP | 426.736 | 321.983 | 104.753 | 8.342.689 | Aufgestockt | +32,5% | |
| LINDEN ADVISORS LP | 7.500.000 | 0 | 7.500.000 | 7.785.000 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 388.347 | 47.160 | 341.187 | 7.592.184 | Aufgestockt | +723,5% | |
| GOLDMAN SACHS GROUP INC | 381.461 | 130.698 | 250.763 | 7.457.563 | Aufgestockt | +191,9% | |
| UBS Group AG | 367.405 | 69.495 | 297.910 | 7.182.768 | Aufgestockt | +428,7% | |
| Sio Capital Management, LLC | 331.730 | 0 | 331.730 | 6.485.322 | Neu | +100,0% | |
| Monashee Investment Management LLC | 3.302.000 | 0 | 3.302.000 | 6.141.362 | Neu | +100,0% | |
| Skandinaviska Enskilda Banken AB (publ) | 163.860 | 0 | 163.860 | 5.949.757 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 275.056 | 15.100 | 259.956 | 5.377.345 | Aufgestockt | +1721,6% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 266.005 | 57.578 | 208.427 | 5.200.398 | Aufgestockt | +362,0% | |
| JENNISON ASSOCIATES LLC | 250.000 | 0 | 250.000 | 4.887.500 | Neu | +100,0% | |
| Maven Securities LTD | 1.650.000 | 0 | 1.650.000 | 4.485.435 | Neu | +100,0% | |
| Eversept Partners, LP | 121.016 | 0 | 121.016 | 4.394.091 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| FMR LLC | 9.082.000 | 7.704.255 | +17,9% | 177.553.101 | 14,06 |
| SR ONE CAPITAL MANAGEMENT, LP | 5.037.854 | 5.037.854 | 0,0% | 98.490.046 | 7,80 |
| NEA Management Company, LLC | 4.023.219 | 3.523.219 | +14,2% | 78.653.931 | 6,23 |
| Enavate Sciences GP, LLC | 3.919.159 | 3.919.159 | 0,0% | 76.619.558 | 6,07 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 65.000.000 | 0 | +100,0% | 67.252.900 | 5,33 |
| FEDERATED HERMES, INC. | 3.127.031 | 2.715.578 | +15,2% | 61.133.456 | 4,84 |
| Polar Capital Holdings Plc | 2.548.444 | 1.057.609 | +141,0% | 49.822.080 | 3,95 |
| Capital International Investors | 2.434.000 | 0 | +100,0% | 47.584.700 | 3,77 |
| Fairmount Funds Management LLC | 2.359.025 | 2.209.025 | +6,8% | 46.118.939 | 3,65 |
| BlackRock, Inc. | 2.037.548 | 1.767.518 | +15,3% | 39.834.063 | 3,16 |
| NVP Associates, LLC | 1.838.482 | 1.838.482 | 0,0% | 35.942.323 | 2,85 |
| ALLIANCEBERNSTEIN L.P. | 897.321 | 18.350 | +4790,0% | 32.581.726 | 2,58 |
| Context Capital Management, LLC | 29.100.000 | 0 | +100,0% | 30.118.500 | 2,39 |
| STATE STREET CORP | 1.470.923 | 438.294 | +235,6% | 28.756.545 | 2,28 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.246.053 | 855.334 | +45,7% | 24.360.335 | 1,93 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.245.391 | 0 | +100,0% | 24.347.394 | 1,93 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.135.935 | 0 | +100,0% | 22.207.529 | 1,76 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20.000.000 | 0 | +100,0% | 19.792.600 | 1,57 |
| EcoR1 Capital, LLC | 789.500 | 789.500 | 0,0% | 15.434.725 | 1,22 |
| Woodline Partners LP | 3.090.525 | 0 | +100,0% | 14.119.764 | 1,12 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 149 | 255,6 | 1.332 |
| 31.12.2025 | ✓ | 125 | 42,2 | 1.515 |
| 30.09.2025 | ✓ | 79 | 34,8 | 765 |
| 30.06.2025 | ✓ | 71 | 33,9 | 323 |
| 31.03.2025 | ✓ | 66 | 32,7 | 253 |
| 31.12.2024 | ✓ | 64 | 32,1 | 258 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Polar Capital Holdings Plc | 1.057.609 | 38.401.783 |
| EcoR1 Capital, LLC | 789.500 | 28.666.745 |
| NEXTBio Capital Management LP | 321.983 | 11.691.203 |
| Point72 Asset Management, L.P. | 403.400 | 10.484.534 |
| BALYASNY ASSET MANAGEMENT L.P. | 193.153 | 7.013.385 |
| Skandinaviska Enskilda Banken AB (publ) | 163.860 | 5.949.757 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 133.439 | 4.845.170 |
| GOLDMAN SACHS GROUP INC | 130.698 | 4.745.644 |
| Caption Management, LLC | 107.700 | 3.910.587 |
| Ikarian Capital, LLC | 93.600 | 3.398.616 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| FMR LLC | 7.704.255 | 2.883.885 | +59.8 % | 279.741.500 |
| FEDERATED HERMES, INC. | 2.715.578 | 853.740 | +45.9 % | 98.602.637 |
| NEA Management Company, LLC | 3.523.219 | 789.500 | +28.9 % | 127.928.082 |
| BlackRock, Inc. | 1.767.518 | 538.877 | +43.9 % | 64.178.579 |
| Fairmount Funds Management LLC | 2.209.025 | 316.219 | +16.7 % | 80.209.698 |
| VANGUARD GROUP INC | 1.453.065 | 290.307 | +25.0 % | 52.760.791 |
| Enavate Sciences GP, LLC | 3.919.159 | 157.800 | +4.2 % | 142.304.663 |
| SR ONE CAPITAL MANAGEMENT, LP | 5.037.854 | 126.315 | +2.6 % | 182.924.479 |
| GEODE CAPITAL MANAGEMENT, LLC | 588.393 | 118.358 | +25.2 % | 21.370.527 |
| STATE STREET CORP | 438.294 | 60.809 | +16.1 % | 15.914.455 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Novo Holdings A/S | 1.450.000 | -550.000 | -27.5 % | 52.649.500 |
| Vivo Capital, LLC | 853.495 | -329.765 | -27.9 % | 30.990.403 |
| Pivotal bioVenture Partners Investment Advisor LLC | 591.991 | -187.054 | -24.0 % | 21.495.193 |
| Rock Springs Capital Management LP | 502.077 | -78.600 | -13.5 % | 18.230.416 |
| ArrowMark Colorado Holdings LLC | 751.161 | -73.507 | -8.9 % | 27.274.656 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 50.636 | -61.976 | -55.0 % | 1.852.265 |
| Eversept Partners, LP | 121.016 | -37.726 | -23.8 % | 4.394.091 |
| MILLENNIUM MANAGEMENT LLC | 49.160 | -22.690 | -31.6 % | 1.785.000 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 83.353 | -13.312 | -13.8 % | 3.026.547 |
| ROYAL BANK OF CANADA | 544 | -11.337 | -95.4 % | 20.000 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 05.05.2026 | MOULDER LEON O JR | Aktivist (13D) | 5,09 % | 3.220.880 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 05.05.2026 | Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 | Aktivist (13D) | 0,10 % | 36.928 | +0,04 pp | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 05.05.2026 | Tellus BioVentures, LLC | Aktivist (13D) | 2,90 % | 1.786.039 | +0,13 pp | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 02.04.2026 | Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 | Aktivist (13D/A) | 0,06 % | 36.928 | -0,04 pp | |
| 02.04.2026 | Tellus BioVentures, LLC | Aktivist (13D/A) | 2,77 % | 1.726.039 | -0,33 pp | |
| 02.04.2026 | Leon O. Moulder, Jr. | Aktivist (13D/A) | 4,79 % | 3.029.921 | -0,37 pp | |
| 05.02.2026 | FMR LLC | Passiv (13G/A) | 14,30 % | 7.652.255 | +3,30 pp | |
| 05.02.2026 | Abigail P. Johnson | Passiv (13G/A) | 14,30 % | 7.652.255 | +3,30 pp | |
| 14.01.2026 | Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 | Aktivist (13D) | 0,10 % | 36.928 | 0,00 pp | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 14.01.2026 | Leon O. Moulder, Jr. | Aktivist (13D) | 5,16 % | 2.806.792 | +0,36 pp | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 14.01.2026 | Tellus BioVentures, LLC | Aktivist (13D) | 3,10 % | 1.672.039 | 0,00 pp | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 14.11.2025 | Novo Holdings A/S | Passiv (13G/A) | 4,70 % | 2.000.000 | -0,60 pp | |
| 15.10.2025 | Ocean Prominent Limited | Passiv (13G) | 9,40 % | 5.000.000 | Neu | |
| 15.10.2025 | InnoCare Pharma Inc. | Passiv (13G) | 9,40 % | 5.000.000 | Neu | |
| 15.10.2025 | InnoCare Pharma Limited | Passiv (13G) | 9,40 % | 5.000.000 | Neu | |
| 14.10.2025 | Enavate Sciences GP, LLC | Aktivist (13D/A) | 7,30 % | 3.919.159 | Neu | |
| 14.10.2025 | Zebra Aggregator, LP | Aktivist (13D/A) | 7,30 % | 3.919.159 | Neu | |
| 14.10.2025 | SR One Capital SMA Partners, LP | Aktivist (13D/A) | 3,60 % | 1.917.895 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | AMZL, LP | Aktivist (13D/A) | 3,60 % | 1.917.895 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | Simeon George | Aktivist (13D/A) | 9,40 % | 5.037.854 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | SR One Capital Fund II Aggregator, LP | Aktivist (13D/A) | 3,60 % | 1.946.564 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | SR One Capital Management, LLC | Aktivist (13D/A) | 9,40 % | 5.037.854 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | SR One Capital Opportunities Fund I, LP | Aktivist (13D/A) | 2,20 % | 1.173.395 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | SR One Capital Opportunities Partners I, LP | Aktivist (13D/A) | 2,20 % | 1.173.395 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | SR One Capital Partners II, LP | Aktivist (13D/A) | 3,60 % | 1.946.564 | Neu | The Funds acquired their respective shares for investment purposes. Depending on market … |
| 14.10.2025 | Juliet Tammenoms Bakker | Aktivist (13D/A) | 4,90 % | 2.607.199 | Neu | The information set forth in Item 4 of the Original Schedule 13D is incorporated herein … |
| 14.10.2025 | Longitude Capital Partners IV, LLC | Aktivist (13D/A) | 3,40 % | 1.832.669 | Neu | The information set forth in Item 4 of the Original Schedule 13D is incorporated herein … |
| 14.10.2025 | Longitude Prime Fund, L.P. | Aktivist (13D/A) | 1,40 % | 774.530 | Neu | The information set forth in Item 4 of the Original Schedule 13D is incorporated herein … |
| 14.10.2025 | Longitude Prime Partners, LLC | Aktivist (13D/A) | 1,40 % | 774.530 | Neu | The information set forth in Item 4 of the Original Schedule 13D is incorporated herein … |
| 14.10.2025 | Longitude Venture Partners IV, L.P. | Aktivist (13D/A) | 3,40 % | 1.832.669 | Neu | The information set forth in Item 4 of the Original Schedule 13D is incorporated herein … |
| 14.10.2025 | Patrick G. Enright | Aktivist (13D/A) | 4,90 % | 2.631.522 | Neu | The information set forth in Item 4 of the Original Schedule 13D is incorporated herein … |
| 09.10.2025 | Tellus BioVentures, LLC | Aktivist (13D/A) | 3,10 % | 1.672.039 | -0,90 pp | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 09.10.2025 | Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 | Aktivist (13D/A) | 0,10 % | 36.928 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 09.10.2025 | Leon O. Moulder, Jr. | Aktivist (13D/A) | 4,80 % | 2.594.662 | -0,20 pp | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 08.09.2025 | Abigail P. Johnson | Passiv (13G/A) | 11,00 % | 4.644.279 | +3,10 pp | |
| 08.09.2025 | FMR LLC | Passiv (13G/A) | 11,00 % | 4.644.279 | +3,10 pp | |
| 06.08.2025 | Abigail P. Johnson | Passiv (13G/A) | 7,90 % | 3.323.534 | +1,10 pp | |
| 06.08.2025 | FMR LLC | Passiv (13G/A) | 7,90 % | 3.323.534 | +1,10 pp | |
| 06.06.2025 | Leon O. Moulder, Jr. | Aktivist (13D) | 5,00 % | 2.098.646 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 06.06.2025 | Tellus BioVentures, LLC | Aktivist (13D) | 4,00 % | 1.672.039 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
Stammdaten
Zenas BioPharma, Inc. ist ein klinisches Biopharmaunternehmen, das sich mit der Entwicklung und Vermarktung von transformativen immunologiebezogenen Therapien befasst. Das führende Produktkandidat ist obexelimab, ein bifunktionaler monoklonaler Antikörper für verschiedene Indikationen, einschließlich Immunglobulin-G4-bezogener Erkrankung, Multipler Sklerose, systemischem Lupus erythematodes und warmem autoimmunem hämolytischen Anämie. Das Unternehmen entwickelt auch ZB002, einen Anti-TNFa-monoklonalen Antikörper; ZB004, eine zytotoxisches-T-Lymphozyten-assoziiertes Antigen-4-Immunglobulin-Fusion; ZB001, einen Anti-Insulin-ähnlichen Wachstumsfaktor-1-Rezeptor-monoklonalen Antikörper; und ZB005, einen Anti-aktiv-Complement-Komponente-1s-monoklonalen Antikörper. Zenas BioPharma, Inc. war früher unter dem Namen Zenas BioPharma (Cayman) Limited bekannt und änderte seinen Namen im August 2023 in Zenas BioPharma, Inc. Das Unternehmen wurde 2019 gegründet und hat seinen Sitz in Waltham, Massachusetts.
Unternehmen & Branche
| Name | Zenas BioPharma, Inc. |
|---|---|
| Ticker | ZBIO |
| CIK | 0001953926 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 98937L105 |
|---|---|
| ISIN | US98937L1052 |
| Typ | Common Stock |
| Marktkapitalisierung | 967,7 Mio. USD |
Bewertung
| KBV (P/B) | 4,00 |
|---|---|
| KUV (P/S) | 96,77 |
| FCF-Rendite | -17,8 % |
Qualität & Bilanz
| Operative Marge | -3.830,6 % vs. -74,3 % (2023) ▼ |
|---|---|
| Nettomarge | -3.777,4 % vs. -74,2 % (2023) ▼ |
| ROIC | -117,3 % |
| Zinsdeckungsgrad | -52,3 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2023. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|
| Bewertung | ||||
| KBV (P/B) | – | 1,10 | 8,17 | |
| KUV (P/S) | – | 68,46 | 197,84 | |
| FCF-Rendite | – | -35,0 % | -8,7 % | |
| Qualität & Bilanz | ||||
| Operative Marge | -74,3 % | -3.277,8 % | -3.830,6 % | |
| Nettomarge | -74,2 % | -3.139,8 % | -3.777,4 % | |
| ROIC | – | -50,1 % | -117,3 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -80.987.000 | -1,46 | 747.682.000 | 335.829.000 | |
| 2025-12-31 | 10-K | 10.000.000 | -377.737.000 | -8,44 | 383.640.000 | 242.144.000 |
| 2025-09-30 | 10-Q | 0 | -51.499.000 | -1,22 | 322.018.000 | 196.428.000 |
| 2025-06-30 | 10-Q | 0 | -52.223.000 | -1,25 | 293.085.000 | 239.626.000 |
| 2025-03-31 | 10-Q | 10.000.000 | -33.573.000 | -0,80 | 333.766.000 | 284.317.000 |
| 2024-12-31 | 10-K | 5.000.000 | -156.988.000 | -11,89 | 369.968.000 | 312.458.000 |
| 2024-09-30 | 10-Q | 0 | -38.606.000 | -5,02 | 403.432.000 | 359.435.000 |
| 2024-06-30 | 10-Q | 0 | -37.977.000 | -24,23 | -288.782.000 | |
| 2024-03-31 | 10-Q | -27.800.000 | -17,89 | -252.495.000 | ||
| 2023-12-31 | 10-K | 50.000.000 | -37.124.000 | -24,25 | 68.180.000 | -225.721.000 |
| 2023-09-30 | 10-Q | 50.000.000 | 35.608.000 | 1,96 | -202.232.000 | |
| 2023-06-30 | 10-Q | -29.047.000 | -238.853.000 | |||
| 2023-03-31 | 10-Q | -19.098.000 | -210.646.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|
| Single Reportable Segment | 10,0 Mio. | 5,0 Mio. | 50,0 Mio. | 100,0 % | +100,0% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 13.05.2026 | – | -1,46 |
| Q3 2025 | 30.09.2025 | 12.11.2025 | 0 USD | -1,22 |
| Q2 2025 | 30.06.2025 | 12.11.2025 | 0 USD | -1,25 |
| Q1 2025 | 31.03.2025 | 13.05.2026 | 10,0 Mio. USD | -0,80 |
| Q3 2024 | 30.09.2024 | 12.11.2025 | 0 USD | -5,02 |
| Q2 2024 | 30.06.2024 | 12.11.2025 | 0 USD | -24,23 |
| Q1 2024 | 31.03.2024 | 12.11.2025 | – | -17,89 |
| Q3 2023 | 30.09.2023 | 12.11.2024 | 50,0 Mio. USD | 1,96 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 13.05.2026 | 10-Q | – | – | SEC » |
| 16.03.2026 | 10-K | 31.12.2025 | 75 Tage | SEC » |
| 12.11.2025 | 10-Q | 30.09.2025 | 43 Tage | SEC » |
| 12.08.2025 | 10-Q | 30.06.2025 | 43 Tage | SEC » |
| 15.05.2025 | 10-Q | 31.03.2025 | 45 Tage | SEC » |
| 11.03.2025 | 10-K | 31.12.2024 | 70 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (13.05.2026)
HOCH Abgang Schlüsselpersonen (13.05.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 13.05.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 12.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 760 | 19,93 | 15.147 |
| 2026-04-28 | 11 | 18,59 | 204 |
| 2026-04-27 | 21 | 18,19 | 382 |
| 2026-04-24 | 5.585 | 18,49 | 103.267 |
| 2026-04-17 | 3.209 | 21,76 | 69.828 |
| 2026-04-15 | 337 | 21,34 | 7.192 |
| 2026-04-14 | 337 | 21,04 | 7.090 |
| 2026-04-10 | 12.392 | 21,28 | 263.702 |
| 2026-04-08 | 2.000 | 22,48 | 44.960 |
| 2026-04-07 | 1.571 | 22,26 | 34.970 |
| 2026-04-02 | 225.964 | 20,36 | 4.600.627 |
| 2026-04-01 | 26 | 19,55 | 508 |
| 2026-03-31 | 804 | 18,23 | 14.657 |
| 2026-03-30 | 108.918 | 18,21 | 1.983.397 |
| 2026-03-27 | 3.668 | 22,16 | 81.283 |
| 2026-03-25 | 45.653 | 21,06 | 961.452 |
| 2026-03-24 | 413 | 20,63 | 8.520 |
| 2026-03-23 | 8.148 | 22,30 | 181.700 |
| 2026-03-20 | 59 | 23,37 | 1.379 |
| 2026-03-19 | 31.171 | 23,03 | 717.868 |
| 2026-03-18 | 2.110 | 23,48 | 49.543 |
| 2026-03-17 | 16.262 | 23,23 | 377.766 |
| 2026-03-09 | 193 | 25,28 | 4.879 |
| 2026-03-04 | 9.615 | 25,18 | 242.106 |
| 2026-03-03 | 10.866 | 25,56 | 277.735 |
| 2026-03-02 | 795 | 26,35 | 20.948 |
| 2026-02-26 | 2.190 | 26,03 | 57.006 |
| 2026-02-25 | 535 | 26,07 | 13.947 |
| 2026-02-23 | 6.604 | 25,88 | 170.912 |
| 2026-02-20 | 78 | 27,02 | 2.108 |
| 2026-02-18 | 7.385 | 26,77 | 197.696 |
| 2026-02-17 | 799 | 26,40 | 21.094 |
| 2026-02-13 | 2.653 | 26,11 | 69.270 |
| 2026-02-10 | 3.898 | 22,48 | 87.627 |
| 2026-02-09 | 1.142 | 21,80 | 24.896 |
| 2026-02-06 | 1.231 | 21,01 | 25.863 |
| 2026-02-05 | 37.886 | 20,66 | 782.725 |
| 2026-01-30 | 3.068 | 20,88 | 64.060 |
| 2026-01-28 | 746 | 20,07 | 14.972 |
| 2026-01-23 | 1.018 | 20,40 | 20.767 |
| 2026-01-22 | 100.297 | 19,59 | 1.964.818 |
| 2026-01-21 | 173 | 20,88 | 3.612 |
| 2026-01-20 | 2.120 | 20,16 | 42.739 |
| 2026-01-15 | 6.878 | 22,56 | 155.168 |
| 2026-01-14 | 63.408 | 21,57 | 1.367.711 |
| 2026-01-13 | 24.251 | 19,78 | 479.685 |
| 2026-01-12 | 37.776 | 16,08 | 607.438 |
| 2026-01-09 | 65.758 | 16,41 | 1.079.089 |
| 2026-01-08 | 37.725 | 16,51 | 622.840 |
| 2026-01-06 | 408 | 16,61 | 6.777 |
| 2025-12-31 | 75 | 36,58 | 2.744 |
| 2025-12-30 | 30 | 39,05 | 1.172 |
| 2025-12-26 | 1.701 | 43,17 | 73.432 |
| 2025-12-24 | 323 | 42,81 | 13.828 |
| 2025-12-23 | 128.050 | 42,33 | 5.420.357 |
| 2025-12-22 | 481 | 36,15 | 17.388 |
| 2025-12-16 | 5.996 | 32,59 | 195.410 |